EnPlusOne Biosciences

EnPlusOne Biosciences is a biotechnology startup founded in 2022, based in the United States. With a slogan of "Harnessing the power and flexibility of enzymes to deliver RNA to the world," EnPlusOne is dedicated to advancing RNA and RNA solutions. The company's ezRNA™ synthesis platform is a significant innovation in RNA manufacturing, offering a sustainable and scalable process for producing therapeutic RNA. This platform's versatility allows for the incorporation of a diverse array of nucleotide modifications, enabling the potential for commercial-scale production. Notably, EnPlusOne's ezRNA™ platform extends its support to a wide range of RNA solution applications. The last significant investment for EnPlusOne Biosciences was a $12.00M Seed Round investment on 30 September 2022, made by notable venture capital firms including Breakout Ventures, Coatue, and Northpond Ventures. This investment signifies a strong show of support from respected players in the venture capital space, indicating confidence in the potential of EnPlusOne's innovative approach. For more information about EnPlusOne Biosciences and its initiatives, visit www.enplusonebio.com.